E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle.
about
Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor-β type I receptor/apoptosis signal-regulating kinase 1/mitogen-activated protein kinase signaling axis.Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice.Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation.MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancerA novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer
P2860
E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
E2F8, a direct target of miR-1 ...... ion via regulating cell cycle.
@en
E2F8, a direct target of miR-1 ...... ion via regulating cell cycle.
@nl
type
label
E2F8, a direct target of miR-1 ...... ion via regulating cell cycle.
@en
E2F8, a direct target of miR-1 ...... ion via regulating cell cycle.
@nl
prefLabel
E2F8, a direct target of miR-1 ...... ion via regulating cell cycle.
@en
E2F8, a direct target of miR-1 ...... ion via regulating cell cycle.
@nl
P2093
P2860
P1476
E2F8, a direct target of miR-1 ...... ion via regulating cell cycle.
@en
P2093
Xianghua Ma
P2860
P2888
P356
10.1186/S13046-017-0504-6
P577
2017-03-07T00:00:00Z
P6179
1084251906